ERBB2 and neoplasm: In terms of nanoprobe-based biomarker detection, nanomaterials are employed to detect circulating tumor cells (CTCs) and tumor biomarkers such as folate receptors, EGFR, and HER2, enabling early diagnosis and prognostic assessment [200].